Soleno Therapeutics Inc (SLNO.OQ)
13 Dec 2017
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|49||2017||President, Chief Executive Officer, Interim Principal Financial and Accounting Officer, Director|
|67||2017||Interim Chief Financial Officer|
|55||2013||Vice President - Research and Development|
|78||2014||Chairman of the Board|
- BRIEF-Soleno Therapeutics Announces $15 Million Private Placement
- BRIEF-Soleno Therapeutics Announces Joint Venture Agreement For Commercialization Of Cosense Monitoring Technology
- BRIEF-Soleno Therapeutics posts Q3 loss $0.24/shr from continuing operations
- BRIEF-Soleno Therapeutics regains compliance with Nasdaq listing requirements
- BRIEF-Soleno Therapeutics receives positive opinion from European orphan committee for DCCR in Prader-Willi Syndrome